Newsletter | March 15, 2023

03.15.23 -- Outsourcing Strategies For Maximizing Drug Exclusivity

New Podcast Episode
Featured Articles
Create The Correct Checklist To Land The Best CDMO

In this article, we discuss CDMO assessment and show how to construct an agreement between partners that favors fluid communication and alignment of business objectives — crucial for a fruitful sponsor-CDMO relationship to diminish overall risk for both.

CDMO Performance On Service Provider Selection Criteria

ISR explains how LSL’s CDMO Leadership Awards and the corresponding market research data can be used by biopharma companies to make more informed CDMO selection decisions and by contract manufacturers to optimize operational and marketing strategies.

Outsourcing Strategies For Maximizing Drug Exclusivity

Frequently, during the CMC development period, novel compositions, processes, and conditions may be discovered that may be used to strategically extend the product's life cycle.

Web-Exclusive Content
The 3 Stages Of Decentralized Trial Maturity

Decentralized clinical trials (DCTs) offer clear benefits to patients and the overall success of the trial, but it can be difficult to know how to address this challenge. This three-stage framework approach will enable you to assess your organization’s current clinical trial innovation maturity and build a plan from there.

Industry Insights
Elemental Impurities Risk Assessment For Finished Drug Products

This webinar reviews the impact of regulatory changes related to elemental impurities testing, guidance on the best routes to compliance, and an overview of the elemental impurities risk assessment process.

Where Can Novel Non-Viral Polymeric Delivery Agents Take Us?

Explore ongoing work to harness different types of HDR templates in order to build cutting-edge systems with the potential to enable point-of-care cell and gene therapy manufacture.

Variables Impacting Cell And Gene Therapy Development Success

Explore four key interconnected variables exerting pressure on therapeutics developers to improve their processes earlier in the product’s development.

Medical Affairs KPIs: How To Create A Framework For Measuring Success

It is possible to develop key performance indicators (KPIs) for your medical affairs team through building a framework for understanding success that embraces both quantitative and qualitative metrics.

Digital Edition
March 2023 Digital Edition

Inside you will find more on:

  • Companies To Watch
  • Leadership Lessons
  • CDMO Work Agreements
  • Diversity On Boards

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.